Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|August 8, 2007
Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviationBarbara Bohle, Tamar Kinaciyan, Marianne Gerstmayr, et al.
Scientific Reports|September 12, 2018
PD-1 has a unique capacity to inhibit allergen-specific human CD4<sup>+</sup> T cell responsesSandra Rosskopf, Beatrice Jahn-Schmid, Klaus Georg Schmetterer, et al.
International Journal of Molecular Sciences|January 14, 2021
Human Embryo Models and Drug DiscoveryMargit Rosner, Manuel Reithofer, Dieter Fink, et al.
European Journal of Immunology|November 25, 2003
Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell levelBarbara Bohle, Astrid Radakovics, Beatrice Jahn-Schmid, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 3, 2002
Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicityBirgit Linhart, Beatrice Jahn-Schmid, Petra Verdino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitopeBeatrice Jahn-Schmid, Peter Kelemen, Martin Himly, et al.
The Journal of Allergy and Clinical Immunology|July 2, 2005
Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergensBeatrice Jahn-Schmid, Astrid Radakovics, Dirk Lüttkopf, et al.
International Archives of Allergy and Immunology|October 29, 2005
The spectrum of allergens in ragweed and mugwort pollenNicole Wopfner, Gabriele Gadermaier, Matthias Egger, et al.
Pageof 6